课题基金 / 基金详情

Molecular biological analysis and treatment for diabetic retinopathy

Molecular biological analysis and treatment for diabetic retinopathy
糖尿病视网膜病变的分子生物学分析与治疗
批准号:
16591774
负责人:
OGATA Nahoko
金额:
$1.92万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2005

项目摘要

项目成果

OGATA Nahoko的其他基金

相似基金

相关文献

中文摘要
翻译
糖尿病视网膜病变是成年人失明的主要原因。我们研究了2型糖尿病模型SDT(自发性糖尿病Torii)大鼠的视网膜变化及其控制糖尿病视网膜病变的分子机制。在一些SDT大鼠的眼睛中发现了与人类增殖性糖尿病视网膜病变(PDR)相似的增殖组织。然而,SDT大鼠视网膜新生血管发生率低,视网膜非灌注区发育不良。SDT大鼠视网膜中血管内皮生长因子(VEGF)和血管生成抑制剂色素上皮衍生因子(PEDF)的表达均升高。PEDF抑制vegf诱导的白细胞停滞。因此,SDT大鼠视网膜中高水平的PEDF可能导致新生血管形成的发生率低,并且没有非灌注区域,这与人类典型的糖尿病视网膜病变不同。在人PDR组织中,VEGF和PEDF均有强表达,但分布不同。血小板衍生微粒(PDMPs)刺激凝血级联并增加白细胞和内皮细胞的粘附,单核细胞衍生微粒(MDMPs)从活化的单核细胞释放并增强促凝活性。这些活动是糖尿病视网膜病变发展的关键事件。PDMPs和MDMPs相互关联,也与活化血小板(CD62P和CD63)和粘附分子(p -选择素和ICAM-1)相关。PDMPs和MDMPs随着糖尿病视网膜病变的进展而升高。因此,MDMPs和PDMPs水平的升高可能会加速糖尿病视网膜病变的进展。
英文摘要
Diabetic retinopathy is a major cause of blindness in adults. We investigate the retinal changes in SDT (Spontaneously Diabetic Torii) rats, a model of type 2 diabetic mellitus, and the molecular mechanisms controlling the diabetic retinopathy. Propliferative tissues that are similar to human proliferative diabetic retinopathy (PDR) are found in eyes of some of the SDT rats. However, SDT rats have a low incidence of retinal neovascularization and poor development of retinal non-perfused areas. Expression of vascular endothelial growth factor (VEGF), a major angiogenic stimulator, and pigment epithelium-derived factor (PEDF), an angiogenic inhibitor, were both increased in the retina of SDT rats. PEDF inhibited the VEGF-induced leukostasis. Thus, the high levels of PEDF in the retina of SDT rats may contribute to the low incidence of neovascular formation and absence of non-perfused areas that did not match the typical diabetic retinopathy in humans. In human PDR tissues, VEGF and PEDF were both strongly expressed, but the distribution was different.Platelet-derived microparticles (PDMPs) stimulate the coagulation cascade and increase leukocyte and endothelial cell adhesions, and monocytes-derived microparticles (MDMPs) are released from activated monocytes and enhance the procoagulant activity. These activities are key events in the development of diabetic retinopathy. PDMPs and MDMPs are correlated with each other and also correlated with activated platelet (CD62P and CD63) and adhesion molecules (P-selectin and ICAM-1). PDMPs and MDMPs are increased according to the progression of diabetic retinopathy. Therefore, increased levels of MDMPs and PDMPs may accelerate the progression of diabetic retinopathy.
期刊论文(61)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1161/01.cir.0000130643.41587.db
发表时间: 2004-06-22
期刊: CIRCULATION
影响因子: 37.8
作者: [Hashiya, N, Jo, N, Morishita, R]
通讯作者: Morishita, R
Deceased levels of pigment epithelium-derived factor in eyes with neuroretinal dystrophic diseases.
患有神经视网膜营养不良性疾病的眼睛中色素上皮衍生因子的水平降低。
DOI: --
发表时间: 2004
期刊: American Journal of Ophthalmology 137
影响因子: --
作者: [Ogata N, Matsuoka M, Imaizumi M, Arichi M, Matsumura M]
通讯作者: Matsumura M
Trans-Tenon's retrobulbare injection of triamcinolone acetonide for diffuse diabetic macular edema
Trans-Tenon球后注射曲安奈德治疗弥漫性糖尿病黄斑水肿
DOI: --
发表时间: 2005
期刊: Japanese Joumal of Ophthalmology 49
影响因子: --
作者: [Wada M, Ogata N, Minamino S, Koriyama M, Higuchi A, Matsumura M]
通讯作者: Matsumura M
Pigment epithelium-derived factor in eyes an aging
眼睛色素上皮衍生因子与衰老
DOI: --
发表时间: 2004
期刊: Japanese Review of Clinical Ophthalmology 98
影响因子: --
作者: [Ogata N, Matsuoka M, Imaizumi M, Arichi M, Matsumura M]
通讯作者: Matsumura M
共 17 条
    Molecular biological study and treatment for diabetic retinopathy
    • 批准号:
      18591943
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.51万
    • 财政年份:
      2006
    • 负责人:
      OGATA Nahoko
    • 依托单位:
    Molecular Mechanism and i Therapy for Choroidal Neovascularization
    • 批准号:
      14571694
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.24万
    • 财政年份:
      2002
    • 负责人:
      OGATA Nahoko
    • 依托单位:
    Control of Ocular Proliferation and Neuroprotection by Gene Therapy and Analysis of These Molecular Mechanisms.
    • 批准号:
      12671730
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.5万
    • 财政年份:
      2000
    • 负责人:
      OGATA Nahoko
    • 依托单位:
    Gene Therapy and Transplantation of Retinal Pigment Epithelium for Ocular Proliferative Deseases and Retinal Degeneration
    • 批准号:
      10671662
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.98万
    • 财政年份:
      1998
    • 负责人:
      OGATA Nahoko
    • 依托单位:
    国内基金
    海外基金
    RGD-68Ga@AuNCs PET监测PRMT5通过VEGFA调节肺腺癌血管新生的功能及机制
    • 批准号:
      82372007
    • 项目类别:
      面上项目
    • 资助金额:
      48.00万元
    • 批准年份:
      2023
    • 负责人:
      谢文晖
    • 依托单位:
    PROCR信号通路介导的血管新生在卵巢组织移植中的作用及机制研究
    • 批准号:
      82371726
    • 项目类别:
      面上项目
    • 资助金额:
      50.00万元
    • 批准年份:
      2023
    • 负责人:
      李文
    • 依托单位:
    RNA编辑型IGFBP7在肿瘤细胞与肿瘤血管微环境中的调控作用及机制研究
    • 批准号:
      32070790
    • 项目类别:
      面上项目
    • 资助金额:
      58.0万元
    • 批准年份:
      2020
    • 负责人:
      徐小燕
    • 依托单位:
    ROBO4对视网膜血管生成(angiogenesis)的调控及其分子机制
    • 批准号:
      81200692
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      23.0万元
    • 批准年份:
      2012
    • 负责人:
      陈凌
    • 依托单位: